Butterfly Network (NYSE:BFLY) is a medical imaging company specializing in point-of-care ultrasound solutions. By combining advanced semiconductor technology with artificial intelligence, the company has developed a compact, handheld ultrasound device designed to provide affordable and accessible imaging for healthcare providers. Its flagship product, Butterfly iQ, integrates seamlessly with mobile devices, allowing clinicians to perform diagnostic scans and capture high-resolution images without the bulk and cost associated with traditional ultrasound systems.
Butterfly iQ operates on a software-driven platform that supports cloud storage, AI-powered image analysis, and remote collaboration. This connectivity enables real-time telemedicine consultations, decision support tools, and streamlined workflow management. Subscription-based services provide customers with regular software updates, educational resources, and technical support, helping hospitals, clinics, and individual practitioners optimize imaging protocols and improve patient care.
Founded in 2011 by entrepreneur and scientist Dr. Jonathan Rothberg, Butterfly Network is headquartered in Guilford, Connecticut. The company went public in 2021 and has since expanded its leadership team to include CEO Dr. Todd Fruchterman, whose background in medical device innovation and digital health guides the company’s strategic growth. Butterfly Network’s board and executive team combine experience in engineering, clinical practice, and finance to drive product development and global expansion.
Butterfly Network serves a diverse range of geographies, including North America, Europe, Asia-Pacific, and Latin America. Its technology is used by large hospital systems, community clinics, academic institutions, and veterinary practices, reflecting broad applicability across human and animal health. Through partnerships with healthcare organizations and research institutions, Butterfly Network aims to advance point-of-care diagnostics, reduce barriers to medical imaging, and improve outcomes for patients worldwide.
